Home Cart Sign in  
Chemical Structure| 751-94-0 Chemical Structure| 751-94-0

Structure of Fusidate Sodium
CAS No.: 751-94-0

Chemical Structure| 751-94-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fusidic Acid Sodium is an antibiotic working by inhibition of protein synthesis in prokaryotes through inhibiting the ribosome-dependent activity of G factor and translocation of peptidyl-tRNA.

Synonyms: Fusidic Acid Sodium; Sodium fusidate; Fusidic Acid (sodium salt)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fusidate Sodium

CAS No. :751-94-0
Formula : C31H47NaO6
M.W : 538.69
SMILES Code : CC(C)=CCC/C(C([O-])=O)=C1[C@@H](OC(C)=O)C[C@]2(C)[C@@]3(C)CC[C@@]4([H])[C@H](C)[C@H](O)CC[C@]4(C)[C@]3([H])[C@H](O)C[C@@]/12[H].[Na+]
Synonyms :
Fusidic Acid Sodium; Sodium fusidate; Fusidic Acid (sodium salt)
MDL No. :MFCD09054714
InChI Key :HJHVQCXHVMGZNC-JCJNLNMISA-M
Pubchem ID :23672955

Safety of Fusidate Sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Escherichia coli B/r strain AS19 1.2 μg/mL To study the effect of FA on transcription-translation coordination, it was found that transcriptional elongation speed was unaffected while translational elongation speed decreased by 50% under FA treatment. Nat Microbiol. 2019 Dec;4(12):2347-2356

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Escherichia coli Culture medium treatment 1.2 μg/mL To study the effect of FA on transcription-translation coordination, it was found that transcriptional elongation speed was unaffected while translational elongation speed decreased by 50% under FA treatment. Nat Microbiol. 2019 Dec;4(12):2347-2356
Mice Unilateral ureteral obstruction (UUO) model Intraperitoneal (i.p.) injection 16 mg/kg/d Daily for seven consecutive days To evaluate the effect of Fusidic acid (FA) on UUO-induced renal fibrosis. Results showed that FA treatment significantly attenuated renal fibrosis. Adv Sci (Weinh). 2023 Sep;10(25):e2301753
Mice Colon cancer lung metastasis model Intraperitoneal injection 16 mg/kg/mouse/day Once daily for 10 days To evaluate the inhibitory effect of FA alone or in combination with 5-FU on colon cancer lung metastasis Mol Cancer Ther. 2018 May;17(5):1101-1113
BALB/c mice MRSA skin infection model Topical administration 2% Twice daily for 5 days To evaluate the efficacy of Fusidate Sodium in an MRSA skin infection model, results showed that 2% Fusidate Sodium significantly reduced the mean bacterial load in infected wounds. Int J Antimicrob Agents. 2016 Mar;47(3):195-201

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03395132 Infected Atopic Dermatitis/Ecz... More >>ema Less << Phase 3 Recruiting January 14, 2020 China ... More >> Children's Hospital, Capital Institute of Pediatrics Not yet recruiting Beijing, China, 100020 Beijing Children's Hospital, Capital Medical University Not yet recruiting Beijing, China, 100045 Peking Union Medical College Hospital Not yet recruiting Beijing, China, 100730 The First Affiliated Hospital of Chongqing Medical University Not yet recruiting Chongqing, China The First Hospital of Dalian Medical University Not yet recruiting Dalian, China, 116011 The Second Hospital of Dalian Medical University Not yet recruiting Dalian, China, 116023 Guangdong General Hospital Recruiting Guangzhou, China, 510080 Dermatology Hospital, China Academy of Medicine and Science Recruiting Nanjing, China, 210042 The Affiliated Hospital of Qingdao University Not yet recruiting Qingdao, China Shanghai Huashan Hospital Recruiting Shanghai, China, 200040 Children's Hospital of Shanghai Not yet recruiting Shanghai, China, 200062 General Hospital of Shenyang Military Not yet recruiting Shenyang, China, 110000 The People's Hospital of Liaoning Province Recruiting Shenyang, China, 110016 The First Affiliated Hospital of Soochow University Not yet recruiting Suzhou, China, 215006 Tongji Hospital of Tongji Medical College of Huazhong Univ. of Science & Technology Recruiting Wuhan, China, 430030 Tangdu Hospital Not yet recruiting Xi'an, China, 710038 Less <<
NCT00133874 Skin Infections, Bacterial Phase 3 Completed - -
NCT03052348 Severe Atopic Dermatitis Not Applicable Not yet recruiting August 30, 2018 South Africa ... More >> Nelson Mandela Academic Hospital Not yet recruiting Mthatha, Eastern Cape, South Africa, 5099 Contact: Avumile Mankahla, MBCHB    0836547566    Mankahla@gmail.com    Contact: Noluvuyo Qikani, MBCHB    0833821188    lmvuyo@gmail.com    King Edward Hospital Not yet recruiting Durban, KwaZulu Natal, South Africa, 4013 Contact: Ncoza Dlova, MBCHB    0312604530    Dlovan@ukzn.ac.za    Red Cross War Memorial Children's Hospital Cape Town, Western Cape, South Africa, 7700 Less <<
NCT02569541 Refractory Bone or Joint Infec... More >>tions Less << Phase 2 Phase 3 Active, not recruiting December 2018 United States, California ... More >> Fountain Valley, California, United States, 92708 San Dimas, California, United States, 91773 Sylmar, California, United States, 91432 Torrance, California, United States, 90502 United States, Florida Tamarac, Florida, United States, 33321 United States, Illinois Springfield, Illinois, United States, 62703 United States, Kentucky Louisville, Kentucky, United States, 40202 United States, Maryland Baltimore, Maryland, United States, 21218 United States, Massachusetts Boston, Massachusetts, United States, 02111 United States, Michigan Detroit, Michigan, United States, 48202 United States, Montana Butte, Montana, United States, 59701 United States, New Jersey Somers Point, New Jersey, United States, 08244 United States, North Carolina Charlotte, North Carolina, United States, 28207 United States, Ohio Cincinnati, Ohio, United States, 45219 Cleveland, Ohio, United States, 44195 United States, Pennsylvania Haverford, Pennsylvania, United States, 19041 Malvern, Pennsylvania, United States, 19355 Philadelphia, Pennsylvania, United States, 19107 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT02570490 Acute Bacterial Skin and Skin ... More >>Structure Infections Less << Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.86mL

0.37mL

0.19mL

9.28mL

1.86mL

0.93mL

18.56mL

3.71mL

1.86mL

References

 

Historical Records

Categories